Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation

PURPOSE: The German Hodgkin Study Group HD11 trial validated 4 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy followed by involved field radiation therapy (IFRT) for early unfavorable Hodgkin lymphoma (HL) patients. However, practitioners often recommend 6 cycles foll...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Radiat Oncol Biol Phys
Auteurs principaux: Gunther, Jillian R., Fanale, Michelle A., Reddy, Jay P., Akhtari, Mani, Smith, Grace L., Pinnix, Chelsea C., Milgrom, Sarah A., Yehia, Zeinab Abou, Allen, Pamela K., Osborne, Eleanor M., Mawlawi, Osama, Dabaja, Bouthaina S.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047754/
https://ncbi.nlm.nih.gov/pubmed/27325479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2016.03.052
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires